Evidence map›Paper›PMID 35629255›Full record

ArticleJournal of personalized medicine2022

Interplay between Comprehensive Inflammation Indices and Redox Biomarkers in Testicular Germ-Cell Tumors.

Uros Bumbasirevic, Nebojsa Bojanic, Tatjana Simic, Bogomir Milojevic, Marko Zivkovic, Tijana Kosanovic, Boris Kajmakovic, Aleksandar Janicic, Otas Durutovic, Milan Radovanovic and 3 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Polymorphisms inLife (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Uros BumbasirevicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-0367-2745
Nebojsa BojanicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Tatjana SimicFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8683-5129
Bogomir MilojevicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-6784-8389
Marko ZivkovicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Tijana KosanovicRadiology Department, The University Hospital 'Dr. Dragisa Misovic-Dedinje', 11000 Belgrade, Serbia.
Boris KajmakovicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Aleksandar JanicicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Otas DurutovicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Milan RadovanovicClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Veljko SantricClinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Milica ZekovicCentre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-2597-3426
Vesna CoricFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-0227-821X

Funding

Wellcome Trust 200110
6 · The paper itself

Abstract

Sustained and dysregulated inflammation, concurrent tumor-induced immune suppression, and oxidative stress are profoundly involved in cancer initiation, presentation, and perpetuation. Within this prospective study, we simultaneously analyzed the preoperative indices of systemic inflammatory response and the representative byproducts of oxidative DNA, protein, and lipid damage with the aim of evaluating their clinical relevance among patients diagnosed with testicular germ-cell tumors (GCT). In the analytical cohort (n = 88, median age 34 years), neutrophil-to-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and C-reactive protein (CRP) were significantly altered in patients with a higher tumor stage (p < 0.05). Highly suggestive correlations were found between NLR, dNLR, and SII and modified nucleoside 8-OHdG. CRP and albumin-to-globulin ratio (AGR) significantly correlated with thiols group level and maximal tumor dimension (p < 0.05). Based on receiver operating characteristic (ROC) curve analyses, all the evaluated pre-orchiectomy inflammation markers demonstrated strong performance in predicting metastatic disease; optimal cut-off points were determined for each indicator. Although further large-scale studies are warranted, inflammatory and redox indices may both complement the established tumor markers and standard clinicopathological prognostic variables and contribute to enhanced personalized risk-assessment among testicular GCT patients.

Indexed as

inflammationoxidative stressredox biomarkerssystemic inflammatory responsetesticular germ-cell tumors

Identifiers

PMID35629255
PMCPMC9143453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.